header-13
Grants

High-content screening of small molecule inhibitors from nature that target prostate cancer metabolism

This project will screen and evaluate a library of 472 novel compounds that were isolated from Australian plants, fungi and marine organisms for their inhibitory activity on several metabolic pathways critical for prostate cancer growth and survival. This project will identify new metabolic inhibitors from nature, provide valuable insights for future large-scale cancer metabolism screens, generate knowledge about regulatory pathways of cancer metabolism and inform and inspire the development of new anticancer agents from nature. 

Investigators

 

Rohan Davis Griffith Institute for Drug Discovery, APCRC-Q
Colleen Nelson APCRC-Q, IHBI, QUT, TRI
Martin Sadowski APCRC-Q, IHBI, QUT, TRI
Jennifer Gunter APCRC-Q, IHBI, QUT, TRI

Administering Institution

Griffith University

Duration

2017 - 2017

Funding

 

Prostate Cancer Foundation of Australia $99618